MAP2K7 and breast cancer: We have also tested the role of RSU1 in cell–ECM adhesion–induced regulation of MEK and ERK signaling in other cell types (e.g., human MDA-MB-231 breast cancer cells), in which RSU1 was depleted using the same CRISPR/Cas9 strategy.